Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.

Zhao, Luqian, Zhu, Zhigang, Lou, Huiling, Zhu, Guodong, Huang, Weimin, Zhang, Shaogang, Liu, Feng·2016·Oncotarget

Cited by (174)

Items 101–174 of 174

  1. A Pilot Study on Ad Libitum Mediterranean Diet Intervention for Women with PCOS: A Mixed-Methods Exploration of Acceptability, Adherence, and Participant Lived Experience
    Nicole Scannell, Anthony M. Villani, Lisa Moran, Evangeline Mantzioris, Stephanie Cowan · 2025 · Nutrients
  2. Analyzing the Challenges, Consequences, and Possible Treatments for Polycystic Ovary Syndrome
    Sumera Zaib, Nehal Rana, Imtiaz Ali Khan, Aqsa Waris, Usama Ahmad · 2023 · Mini-Reviews in Medicinal Chemistry
  3. Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications
    Phoutdavone Phimphasone‐Brady, Kaitlin V. Ross, Alexander Z. Zhang, Madeleine N. Sehrt, Kathryn M. McKenney, Lindsay G. Lebin · 2024 · Current Psychiatry Reports
  4. Type and Frequency in Use of Nutraceutical and Micronutrient Supplementation for the Management of Polycystic Ovary Syndrome: A Systematic Scoping Review
    Nicole Scannell, Evangeline Mantzioris, Vibhuti Samarth Rao, Chhiti Pandey, Carolyn Ee, Aya Mousa, Lisa Moran, Anthony M. Villani · 2023 · Biomedicines
  5. Atypical Presentation of Myocardial Infarction in a Young Patient With Polycystic Ovarian Syndrome
    Shobha Mandal, Ravi Ranjan Pradhan, Barbara Mols Kowalczewski · 2020 · Cureus
  6. LRH-1 high expression in the ovarian granulosa cells of PCOS patients
    Xiao Yang, Qiumin Wang, Ying Wang, Tian Song, Yanjun Zheng, Wenqi Wang, Yuhua Shi · 2021 · Endocrine
  7. Circulating microparticles as indicators of cardiometabolic risk in PCOS
    Banafsheh Yalameha, Hamid Reza Nejabati, Mohammad Nouri · 2022 · Clinica Chimica Acta
  8. Sex-Related Differences in the Prevalence of Classical, Non-Classical Risk Factors and Management of the Chronic Coronary Syndrome
    Paweł Muszyński, Elżbieta Pawluczuk, Marta Pasławska, Maciej Kowalczuk, Julia Kozakiewicz, Natalia Sot-Muszyńska, Marcin Kożuch, Sławomir Dobrzycki · 2023 · Journal of Clinical Medicine
  9. The impact of lifestyle on the reproductive, metabolic, and psychological well-being of women with polycystic ovary syndrome (PCOS)
    Dylan A. Cutler · 2019 · cIRcle (University of British Columbia)
  10. Impact of COVID-19 Restriction on Weight, Physical Activity, Diet and Psychological Distress on People with PCOS
    Margaret McGowan, Siew S. Lim, Sharleen L. O'Reilly, Cheryce L. Harrison, Joanne Enticott, Helena Jane Teede, Stephanie Cowan, Lisa Moran · 2023 · Nutrients
  11. Idiopathic Intracranial Hypertension and Cardiovascular Diseases Risk in the United Kingdom Women: An Obesity-Adjusted Risk Analysis Using Indirect Standardization
    Ahmed Y. Azzam, Mahmoud M Morsy, Mohamed Hatem Ellabban, Ahmed M. Morsy, Adham Adel Zahran, Mahmoud Nassar, Omar S. Elsayed, Adam Elswedy, Osman Elamin, Ahmed Saad Al Zomia et al. · 2024 · medRxiv
  12. Family history of premature myocardial infarction modifies the associations between bilateral oophorectomy and cardiovascular disease mortality in a US national cohort of postmenopausal women
    Duke Appiah, Chike C. Nwabuo, Damilola R. Owoade, Jaffer Samad, Imo Ebong, Stephen J. Winters · 2020 · Menopause The Journal of The North American Menopause Society
  13. Impact of the Individual Counseling Program for Polycystic Ovarya Syndrome Management Among University Students
    O Dilek, Şenay Ünsal Atan, Fatih Çelik · 2022 · Nigerian Journal of Clinical Practice
  14. Number of prior live births is associated with higher arterial stiffness but not its change in older women: the atherosclerosis risk in communities study
    Alison N. Bonner, Shantal Jayawickreme, Angela M. Malek, Catherine J. Vladutiu, Clare Oliver‐Williams, Yamnia I. Cortés, Hirofumi Tanaka, Michelle L. Meyer · 2023 · Frontiers in Cardiovascular Medicine
  15. Metabolic dysfunctions in polycystic ovary syndrome
    Mehrin Rahman, Fahim T Rahman, Md Uzzwal Mallik, Joysree Saha, Md Mujibur Rahman, Khan Abul Kalam Azad · 2024 · Journal of Medicine
  16. Inter-relationship between polycystic ovary syndrome and metabolic syndrome
    Mohd Ashraf Ganie, Abid Rasool, Tajali Sahar, Mohammad Ishaq Geer · 2024 · Elsevier eBooks
  17. Reproductive-associated risk factors and incident coronary heart disease in women: an umbrella review
    Khadeeja Alnefaie, Jennifer R. Dungan · 2025 · American Heart Journal Plus Cardiology Research and Practice
  18. Exploring potential associations and biomarkers linked polycystic ovarian syndrome with atherosclerosis via comprehensive bioinformatics analysis, machine learning, and animal experiments
    Xiaoxuan Zhao, Yuanyuan Zhang, Qingnan Fan, Yuanfang He, Yiming Ma, Miao Sun, Yang Zhao, Yuepeng Jiang, Dan Jia · 2025 · Functional & Integrative Genomics
  19. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
    Dorte Glintborg, Katrine Hass Rubin, Mads Nybo, Bo Abrahamsen, Marianne Andersen · 2018 · Endocrine Abstracts
  20. Dysregulation of Endothelial cell markers in polycystic ovary syndrome
    Preeti Borde, Sara Anjum Niinuma, Haniya Habib, Ashleigh Suzu-Nishio Takemoto, Manjula Nandakumar, Thozhukat Sathyapalan, Alexandra E. Butler, Stephen Lawrence Atkin · 2026 · Scientific Reports
  21. Coronary Artery Disease in Women: Sex-Specific Pathophysiology, Risk Factors, Clinical Presentation and Management
    Kassiani-Maria Nastouli, Anastasiοs Apostolos, Maria Bozika, Georgios Boliaris, Panagιotis Iliakis, Nikolaos Ktenopoulos, Panayotis K. Vlachakis, Paschalis Karakasis, Theoni Theodoropoulou, Nikolaos Tsiamis et al. · 2026 · Medicina
  22. A Comparative Study of Food Intake and Adipose Tissue Distribution in Saudi Women with Polycystic Ovarian Syndrome
    Nujud H. Hurayb, Ghedeir Muslem Alshammari, Abdulrahman Saleh Al-Khalifa, Nora O. Alafif, Dania Al‐Jaroudi, Mohammed A. Mohammed, Abu ElGasim A. Yagoub, Mohammed Abdo Yahya · 2024 · Healthcare
  23. Spontaneous coronary artery dissection in a young woman with polycystic ovarian syndrome
    Marco Mirra, Nertil Kola, Giacomo Mattiello, Carmine Morisco, Letìzia Spinelli · 2016 · The American Journal of Emergency Medicine
  24. Polycystic Ovary Syndrome and Cardiovascular Disease: An Enigmatic Relationship
    Srabani Mukherjee · 2017 · Global Journal of Reproductive Medicine
  25. Levels of methylated arginines and L-arginine in patients with polycystic ovary syndrome: a promising approach in clinical evaluation
    Ozgur OZTAN, Gökçen Erdoğan, Çoşkun ŞİMŞİR, Vugar Ali Türksoy, Gülsüm Abuşoğlu, Lütfiye Tutkun, Serdar Deniz, Mehmet Erdem Alagüney · 2021 · Anatolian Current Medical Journal
  26. Psychological factors and atherosclerotic cardiovascular disease development in women: A narrative review
    Elpiniki Vlachopoulou, Christina Vassou, Demosthenes B. Panagiotakos · 2022 · Journal of Atherosclerosis Prevention and Treatment
  27. Cardiac function and tolerance to ischemia/reperfusion injury in a rat model of polycystic ovary syndrome during the postmenopausal period
    Mahsa Noroozzadeh, Mohammad Reza Raoufy, Razieh Bidhendi Yarandi, Farzaneh Faraji Shahrivar, Naghmeh Moghimi, Fahimeh Ramezani Tehrani · 2020 · Life Sciences
  28. Venciendo al síndrome del ovario poliquístico con intervenciones en el estilo de vida
    Antonio Ruiz‐García · 2022 · Medicina de Familia SEMERGEN
  29. The Role of Lipid Accumulation Product (LAP) as a Metabolic Indicator in Polycystic Ovary Syndrome (PCOS)
    Ioannis Prokopakis, Vasilios Pergialiotis, Ioakeim Sapantzoglou, Eleftherios Zachariou, Antonios Koutras, Nikolaos Thomakos, Kalliopi I. Pappa · 2023 · Hellenic Journal of Obstetrics and Gynecology
  30. Suppression of protein kinase RNA-like endoplasmic reticulum kinase by probiotics circumvents cardiovascular risk profile in experimentally induced PCOS model
    Stephanie Esosa Joy Areloegbe, Anderson Linus Enye, Kehinde Samuel Olaniyi · 2025 · Canadian Journal of Physiology and Pharmacology
  31. A multidisciplinary approach to polycystic ovary syndrome: synergy of methods
    Elena Nikolaevna Andreeva, Galina Afanas'evna Mel'nichenko, Maria Igorevna Yarmolinskaya, Marina Borisovna Khamoshina, Л. В. Сутурина, Бурумкулова Фатима Фархадовна, O. R. Grigoryan, Olga Yu. Sukhareva, Alena Viktorovna Tiselko, Svetlana Yu. Vorotnikova et al. · 2025 · Bulletin of Reproductive Health
  32. Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
    Gláucia Maria Moraes de Oliveira, Maria Cristina Costa de Almeida, Cynthia Melissa Valério, Fernando M. A. Giuffrida, Larissa Neto Espíndola, Maria Cristina de Oliveira Izar, Celi Marques-Santos, Cláudia Maria Vilas Freire, Carlos Japhet da Matta Albuquerque, Antônio Carlos Palandri Chagas et al. · 2025 · Arquivos Brasileiros de Cardiologia
  33. Posicionamento sobre a Saúde Cardiometabólica ao Longo do Ciclo de Vida da Mulher – 2025
    Gláucia Maria Moraes de Oliveira, Maria Cristina Costa de Almeida, Cynthia Melissa Valério, Fernando M. A. Giuffrida, Larissa Neto Espíndola, Maria Cristina de Oliveira Izar, Celi Marques-Santos, Cláudia Maria Vilas Freire, Carlos Japhet da Matta Albuquerque, Antônio Carlos Palandri Chagas et al. · 2025 · Arquivos Brasileiros de Cardiologia
  34. Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
    Gláucia Maria Moraes de Oliveira, Maria Cristina Costa de Almeida, Cynthia Melissa Valério, Fernando M. A. Giuffrida, Larissa Neto Espíndola, Maria Cristina de Oliveira Izar, Celi Marques-Santos, Cláudia Maria Vilas Freire, Carlos Japhet da Matta Albuquerque, Antônio Carlos Palandri Chagas et al. · 2025 · Revista Brasileira Ginecologia e Obstetrícia
  35. MASLD coexisting with PCOS increases cardiometabolic risk
    Oyekoya Taiwo Ayonrinde, Trevor Anthony Mori, Leon A. Adams, Lawrence Joseph Beilin, John Kevin Olynyk, Roger J Hart · 2026 · The Journal of Clinical Endocrinology & Metabolism
  36. Differences in clinical characteristics and cardiovascular disease risk prediction among Chinese women with polycystic ovary syndrome phenotypes: a cross-sectional study
    Ziye Gong, Danyang Li, Xuan Li, Jinjin Tian, Jing Guo, Yuying Zhao, Yin Lu, Shan Gao, Ming Li · 2026 · Frontiers in Endocrinology
  37. Brustschmerz und kardiovaskuläre Erkrankungen bei Frauen
    Janet-Jacqueline Olic, Andrea Baessler, Marcus Fischer · 2023 · Herz
  38. A Complete Overview of the Polycystic Ovarian Syndrome with Recent Advancement in Clinical Trial
    Swarupananda Mukherjee, Deepti Rai, Debjit Ghoshal, Tania Chakraborty, Dipanjan Karati · 2024 · Current Women s Health Reviews
  39. Cardiovascular Risk is Independently Associated with Body Mass Index in Women with Polycystic Ovarian Syndrome in Lagos, Nigeria
    Mathias Abiodun Emokpae, Temitope Olukemi Van-lare, Elizabeth Moyinoluwa Babatunde · 2024 · Fertility & Reproduction
  40. Polycystic Ovary Syndrome-Related Risks in Postmenopausal Women
    Panagiotis G. Anagnostis, Stavroula Α. Paschou, Irene V. Lambrinoudaki, Dimitrios G. Goulis · 2019 · Springer eBooks
  41. Sex and Gender Differences in Cardiovascular Disease
    Lena M. Mathews, Pranav Chandrashekar, Megha Prasad, Virginia M. Miller, Kavita Sharma, Tara Sedlak, C. Noel Bairey Merz, Pamela Ouyang · 2017 · Elsevier eBooks
  42. OBSOLETE: Sex and Gender Differences in Cardiovascular Disease
    Pamela Ouyang · 2017 · Elsevier eBooks
  43. Overview of Some Risk Factors in Cardiovascular Disease
    Elena Cojocaru, Alexandra Maștaleru, Bogdan-Ionel Tamba, Raluca Vasile, Razvan Cosmin Tudor, Carmen Valerica Ripa, Roxana Gabriela Cobzaru, Maria Magdalena Leon · 2017 · InTech eBooks
  44. KARDİYOVASKÜLER SİSTEM HASTALIKLARINDA RİSK FAKTÖRÜ OLAN HİPERHOMOSİSTEİNEMİ’NİN POLİKİSTİK OVER SENDROMUNDAKİ YERİ
    Burcu İMRE, Duygu İmre Yetkin, Cavidan Gülerman · 2021 · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
  45. Prevention of Cardiovascular Disease
    Garima V. Sharma, Anum Minhas, Erin D. Michos · 2021 · Elsevier eBooks
  46. Role of Gut Microbiome in Polycystic Ovary Syndrome
    Zekra Zaghi, Seyed Davar Siadat, Hanieh‐Sadat Ejtahed, Nooshin Shirzad, Shirin Hasani‐Ranjbar, Bagher A. Larijani · 2021 · DOAJ (DOAJ: Directory of Open Access Journals)
  47. Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
    Rhiannon Kate Patten · 2021 · Victoria University Research Repository (Victoria University)
  48. Physical activity and cardiovascular disease risk in women with polycystic ovary syndrome
    Amie Woodward · 2021 · Sheffield Hallam University
  49. Exercise interventions in women with Polycystic Ovary Syndrome
    Alba Moreno‐Asso, Rhiannon Kate Patten, Luke C. McIlvenna · 2022 · Elsevier eBooks
  50. Polycystic ovarian syndrome and reproductive failure
    Joseph Duero, Reshef Tal · 2022 · Elsevier eBooks
  51. Cardiovascular risk reduction in polycystic ovary syndrome
    Pirbhat Shams, Intisar Ahmed, Zainab Z. Samad · 2023 · Elsevier eBooks
  52. Papel do excesso de andrógenos no perfil metabólico e inflamatório de mulheres com síndrome do ovário policístico
    Thais P. Rocha · 2022
  53. Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in treatment of Patients with Polycystic Ovary Syndrome: A systemic Review of Metabolic and Cardiovascular Outcomes
    Dev Pate, J. Aponte John, Ranita Bodepudi, Saniya Seher, Shenel A Khan, S Yu William Emmanuel, Vivig Shantha, Resheek Nerella, Basim Shaman, Pousette Hamid · 2024 · Journal For International Medical Graduates
  54. Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS)
    Irene V. Lambrinoudaki, Eleni Armeni · 2024 · Elsevier eBooks
  55. Atypical Manifestation of Acute Myocardial Infarction (AMI) in a Vicenarian Woman With Polycystic Ovary Syndrome (PCOS) Undergoing Assisted Reproductive Technology (ART) Treatment: A Case Report
    Nikita Hulke, Shilpa Dutta, Avinash B Taksande · 2024 · Cureus
  56. Migraine and Cardiovascular Risk in Women
    Linda Al‐Hassany, Antoinette MaassenVanDenBrink · 2024 · Springer eBooks
  57. Cardiovascular Health in Women
    Aury V Garcia, Yorgos Strangas · 2025 · Primary Care Clinics in Office Practice
  58. Cardiovascular risk management in women in peri- and postmenopause: a global health challenge (literature review)
    O. A. Minyailo, O.A. Melkozerova, Yu. A. Semenov, Ya. L. Gabinsky, Anna A. Mikhelson · 2025 · Vestnik ohrany materinstva i mladenčestva.
  59. Role of Hyperandrogenism in PCOS Pathogenesis
    Faria Afsana · 2025 · BENTHAM SCIENCE PUBLISHERS eBooks
  60. Additional file 4 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  61. Additional file 3 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  62. Additional file 5 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  63. Additional file 2 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  64. Additional file 7 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  65. Additional file 6 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  66. Additional file 1 of Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
    Mirzohreh, Seyedeh Tarlan, Padideh Panahi, Fariba Heidari · 2024 · Figshare
  67. Risk of Cardiovascular Disease among Women with PCOS
    Aditi Chopra, Saptarshi Bhattacharya · 2025 · BENTHAM SCIENCE PUBLISHERS eBooks
  68. Constraint Heart
    Pitt O. Lim · 2025 · Springer eBooks
  69. Sex and Gender Differences in Cardiovascular Disease
    Puja K. Mehta, Lena M. Mathews, Pranav Chandrashekar, Megha Prasad, Virginia M. Miller, Kavita Sharma, Tara Sedlak, C Noel Bairey Merz, Pamela Ouyang, Viola Vaccarino · 2026 · Elsevier eBooks
  70. KARDİYOVASKÜLER SİSTEM HASTALIKLARINDA RİSK FAKTÖRÜ OLAN HİPERHOMOSİSTEİNEMİ’NİN POLİKİSTİK OVER SENDROMUNDAKİ YERİ
    Burcu İMRE, Duygu İmre Yetkin, Cavidan Gülerman · 2020 · DergiPark (Istanbul University)
  71. Cardiovascular Health Across and Beyond the Reproductive Lifespan: Early Years: Menarche, Menstrual Cycle Irregularity, PCOS, and Cardiovascular Risk
    Semenawit Burka, Carla P. Rodriguez, Petal Elder-Odame, Erin D. Michos · 2026 · Springer eBooks
  72. Aumento do risco cardiovascular em mulheres com síndrome do ovário policístico
    Giovana Paula Caetano, Kelen Cristina Estavanate de Castro, Natália de Fátima Gonçalves Amâncio · 2022 · Femina
  73. ApoB and LDL partially explain the association between family history of diabetes and lower clinical pregnancy in women who conceived with PCOS
    Hang Ge, Hui Chang, Zhao-Xuan Sun, Mu-Xin Guan, Jian-Nan Yu, An-Qi Li, Zhu Meng-yi, Jingshu Gao, X. K. Wu · 2026 · Frontiers in Nutrition
  74. A Cross-Sectional Exploratory Study of Endothelial Biomarkers in Non-Obese Women with and Without Polyendocrine Metabolic Ovarian Syndrome
    Manjula Nandakumar, Sana Waris, Thozhukat Sathyapalan, Alexandra E. Butler, Stephen Lawrence Atkin · 2026 · International Journal of Molecular Sciences